Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Center for Drug Evaluation and Research

This article was originally published in The Tan Sheet

Executive Summary

Deputy Director Gerald Meyer assumes the post of CDER interim director on Nov. 1; former Director Carl Peck's last official day as director was Oct. 29. Peck retired from FDA to join Leiden University in The Netherlands as a clinical drug research professor ("The Tan Sheet" May 24, p. 9). Meyer will retire from the agency in January. Candidates for permanent director of CDER are under consideration by Commissioner David Kessler and Deputy Commissioner for Operations Jane Henney.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS082109

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel